Focus
CAR-T-cell therapy
CAR T-Cell Therapy for Blood Cancer Rarely Linked to Other Cancers: Stanford Medicine Study
The FDA put a black-box warning on the treatment after receiving 11 reports of T-cell lymphomas in patients receiving it, but new research says the risk is low.
FDA Seeks New Boxed Warning for CAR-T Cancer Therapies After Cancer Risk Reports
However, the FDA said the benefits of the treatment still outweigh the risks.
AstraZeneca to Acquire Chinese Firm to Boost Cell Therapy Portfolio
An analyst said the proposed acquisition of Gracell ould be AstraZeneca’s way of getting more into cell therapy.
CAR T-Cell Cancer Therapy Potentially Linked to Rare Blood Cancer, Experts Respond
CAR T therapies are currently used to treat blood cancers, including multiple myelomas, leukemias, and B-cell lymphomas.
